产品简要
公司名称 :
赛默飞世尔
其他品牌 :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
产品类型 :
抗体
产品名称 :
血管内皮生长因子单克隆抗体(JH121)
目录 :
MA5-13182
规格 :
500微升
价格 :
美国419
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
JH121
反应物种 :
人类, 小鼠, 大鼠, 犬, 牛, domestic rabbit
应用 :
免疫印迹, 酶联免疫吸附测定, 免疫组化, 免疫细胞化学, 免疫组化-石蜡切片, 抑制或激活实验
更多信息或购买 :
文章摘录数: 109
出版应用/物种/样本/稀释 | 参考文献 |
---|---|
| |
| |
| |
| |
| Lattanzio R, La Sorda R, Facciolo F, Sioletic S, Lauriola L, Martucci R, et al. Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study. Lung Cancer. 2014;85:191-6 pubmed 出版商
|
| |
| |
| |
| Shimoda Y, Ogawa Y, Watanabe M, Tominaga T. Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistochemically negative pituitary adenoma--possible involvement in tumor aggressiveness. Endocr Res. 2013;38:242-50 pubmed 出版商
|
| |
| |
| Karetsi E, Ioannou M, Kerenidi T, Minas M, Molyvdas P, Gourgoulianis K, et al. Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer. Clinics (Sao Paulo). 2012;67:1373-8 pubmed
|
| |
| Mitselou A, Skoufi U, Tsimogiannis K, Briasoulis E, Vougiouklakis T, Arvanitis D, et al. Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma. Anticancer Res. 2012;32:3977-85 pubmed
|
| Hu Y, Kong S, Kong H, Wu J, Chen Z. Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells. Chin Med J (Engl). 2012;125:2025-31 pubmed
|
| |
| Al Salam S, Balalaa N, Faour I, Akhter S, Alashari M. HIF-1?, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature. Int J Clin Exp Pathol. 2012;5:247-53 pubmed
|
| Kovacs J, Gurzu S, Jung J, Szederjesi J, Copotoiu S, Copotoiu R, et al. Clinico-pathological particularities of the shock-related pancreatitis. Pathol Oncol Res. 2012;18:977-81 pubmed
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| Azamfirei L, Gurzu S, Solomon R, Copotoiu R, Copotoiu S, Jung I, et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiol. 2010;76:609-16 pubmed
|
| |
| |
| |
| Johansson A, Olerud J, Johansson M, Carlsson P. Angiostatic factors normally restrict islet endothelial cell proliferation and migration: implications for islet transplantation. Transpl Int. 2009;22:1182-8 pubmed
|
| |
| |
| |
| |
| |
| |
| Smith V, Wirth G, Fiebig H, Burger A. Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents. Cancer Genomics Proteomics. 2008;5:263-73 pubmed
|
| Tolstanova G, Khomenko T, Deng X, Chen L, Tarnawski A, Ahluwalia A, et al. Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF. J Pharmacol Exp Ther. 2009;328:749-57 pubmed 出版商
|
| |
| |
| |
| |
| |
| |
| |
| |
| Constantinides C, Tyritzis S, Evangelou C, Kyroudi A, Liatsikos E, Karamessinis P, et al. Vascular endothelial growth factor protein expression in a renal ablation rabbit model under prolonged warm and cold ischemia. Am J Nephrol. 2008;28:438-45 pubmed
|
| Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura A, Pinto M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol. 2008;15:69-79 pubmed
|
| Hong S, Chang S, Yeom D, Kang J, Hong K. Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. Anticancer Drugs. 2007;18:1005-14 pubmed
|
| Skarlos D, Bai M, Goussia A, Samantas E, Galani E, Tsavdaridis D, et al. Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group. Anticancer Res. 2007;27:2973-83 pubmed
|
| Lee D, Kuo H, Chen C, Hsu J, Chou C, Wei Y, et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell. 2007;130:440-55 pubmed
|
| Tao X, Huang Y, Li R, Qing R, Ma L, Rhodus N, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:661-9 pubmed
|
| Kaygusuz G, Tulunay O, Baltaci S, Gogus O. Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int Urol Nephrol. 2007;39:841-50 pubmed
|
| Ong C, Khoo Y, Tan E, Mukhopadhyay A, Do D, Han H, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol. 2007;211:95-108 pubmed
|
| Yasuda H, Nakayama K, Watanabe M, Suzuki S, Fuji H, Okinaga S, et al. Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clin Cancer Res. 2006;12:6748-57 pubmed
|
| Ioachim E, Michael M, Salmas M, Michael M, Stavropoulos N, Malamou Mitsi V. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins. Urol Int. 2006;77:255-63 pubmed
|
| Yang L, Lu W, Huang G, Wang W. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer. 2006;6:110 pubmed
|
| Karavasilis V, Malamou Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Pavlidis N. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. Int J Gynecol Cancer. 2006;16 Suppl 1:241-6 pubmed
|
| Kim S, Cho N, Kim K, Lee J, Koo B, Kim J, et al. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol. 2006;93:330-7 pubmed
|
| Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N, et al. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun. 2006;341:755-62 pubmed
|
| Lin Y, Lai M, Lei H, Wing L. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology. 2006;147:1278-86 pubmed
|
| Pakos E, Goussia A, Tsekeris P, Papachristou D, Stefanou D, Agnantis N. Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas. Anticancer Res. 2005;25:3591-6 pubmed
|
| Arbos M, Ferrando J, Quiles M, Vidal J, Lopez Cano M, Gil J, et al. Improved surgical mesh integration into the rat abdominal wall with arginine administration. Biomaterials. 2006;27:758-68 pubmed
|
| Rosen D, Wang L, Atkinson J, Yu Y, Lu K, Diamandis E, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol. 2005;99:267-77 pubmed
|
| Saylam G, Yücel O, Sungur A, Onerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2006;70:227-34 pubmed
|
| Isobe N, Kitabayashi M, Yoshimura Y. Microvascular distribution and vascular endothelial growth factor expression in bovine cystic follicles. Domest Anim Endocrinol. 2005;29:634-45 pubmed
|
| Invernizzi R, Travaglino E, De Amici M, Brugnatelli S, Ramajoli I, Rovati B, et al. Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes. Leuk Res. 2005;29:641-7 pubmed
|
| Huang G, Yang L, Lu W. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol. 2005;11:1705-8 pubmed
|
| Karavasilis V, Malamou Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, et al. Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer. 2005;5:25 pubmed
|
| Kyzas P, Stefanou D, Batistatou A, Agnantis N. Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2. Mod Pathol. 2005;18:485-94 pubmed
|
Yata K, Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia. 2004;18:1891-7 pubmed
| |
Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res. 2004;10:3490-9 pubmed
| |
Stefanou D, Batistatou A, Kamina S, Arkoumani E, Papachristou D, Agnantis N. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo. 2004;18:155-60 pubmed
| |
Mira E, Lacalle R, Buesa J, de Buitrago G, Jimenez Baranda S, Gomez Mouton C, et al. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci. 2004;117:1847-57 pubmed
| |
Bangoura G, Yang L, Huang G, Wang W. Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma. World J Gastroenterol. 2004;10:525-30 pubmed
| |
Tufan A, Satiroglu Tufan N. The effect of ethanol exposure on extraembryonic vascular development in the chick area vasculosa. Cells Tissues Organs. 2003;175:84-97 pubmed
| |
Hedberg Y, Ljungberg B, Roos G, Landberg G. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer. 2003;88:1417-23 pubmed
| |
Kaigler D, Krebsbach P, Polverini P, Mooney D. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng. 2003;9:95-103 pubmed
| |
Matalliotakis I, Goumenou A, Koumantakis G, Athanassakis I, Dionyssopoulou E, Neonaki M, et al. Expression of serum human leukocyte antigen and growth factor levels in a Greek family with familial endometriosis. J Soc Gynecol Investig. 2003;10:118-21 pubmed
| |
Lord R, Park J, Wickramasinghe K, Demeester S, Oberg S, Salonga D, et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg. 2003;125:246-53 pubmed
| |
Matalliotakis I, Goumenou A, Koumantakis G, Neonaki M, Koumantakis E, Dionyssopoulou E, et al. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol. 2003;3:81-9 pubmed
| |
Restucci B, Papparella S, Maiolino P, De Vico G. Expression of vascular endothelial growth factor in canine mammary tumors. Vet Pathol. 2002;39:488-93 pubmed
| |
Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza E, Nobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002;69:247-54 pubmed
| |
Onita T, Ji P, Xuan J, Sakai H, Kanetake H, Maxwell P, et al. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin Cancer Res. 2002;8:471-80 pubmed
| |
Quan Z, Wu K, Wang J, Shi W, Zhang Z, Merrell R. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. J Am Coll Surg. 2001;193:380-3 pubmed
| |
Grunstein J, Masbad J, Hickey R, Giordano F, Johnson R. Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. Mol Cell Biol. 2000;20:7282-91 pubmed
| |
Heffelfinger S, Miller M, Yassin R, Gear R. Angiogenic growth factors in preinvasive breast disease. Clin Cancer Res. 1999;5:2867-76 pubmed
|
图像
图像 1 :
Formalin-fixed, paraffin-embedded human angiosarcoma stained with VEGF antibody using peroxidase-conjugate and AEC chromogen. Note cytoplasmic staining of tumor cells.
产品信息
产品类型 :
抗体
产品名称 :
血管内皮生长因子单克隆抗体(JH121)
目录# :
MA5-13182
规格 :
500微升
价格 :
美国419
克隆性 :
单克隆
纯度 :
蛋白质G
宿主 :
小鼠
反应物种 :
人类, 小鼠, 兔
应用 :
Immunocytochemistry: 1:20-1:100, Immunohistochemistry (Paraffin): 1:20, Western Blot: 1-2 µg/mL
物种 :
人类, 小鼠, 兔
克隆 :
JH121
抗体亚型 :
IgG1, kappa
储存 :
4° C
描述 :
VEGF (vascular endothelial growth factor) which is a 45 kDa homodimeric, disulfide-linked glycoprotein involved in angiogenesis which promotes tumor progression and metastasis. VEGF has a variety of effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxis, and vascular permeability. The VEGF family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis. Most tumors have the absolute requirement of angiogenesis, and VEGF has been described as the most potent angiogenic cytokine linked to this process. To date 5 different isoforms of VEGF have been described. These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells. VEGF and its high-affinity binding receptors, the tyrosine kinases FLK1 and FLT1, are thought to be important for the development of embryonic vasculature. Studies have shown that an alternately spliced form of FLT1 produces a soluble protein, termed sFLT1, which binds vascular endothelial growth factor with high affinity, playing an inhibitory role in angiogenesis. Elevated levels of VEGF is linked to POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes) also known as Crow-Fukase syndrome which affects multiple organs in the body.
免疫原 :
重组人类VEGF121
格式 :
液体
应用w/稀释 :
Immunocytochemistry: 1:20-1:100, Immunohistochemistry (Paraffin): 1:20, Western Blot: 1-2 µg/mL
别名 :
angiogenic factor; etID309976.16; eVEGF120; eVEGF164; human VEGF121 homolog; MGC70609; MVCD1; ovine vascular endothelial growth factor; RP1-261G23.1; unnamed protein product; VAS; vascular endothelial growth factor; vascular endothelial growth factor (VEGF) precursor; vascular endothelial growth factor 121 isoform; vascular endothelial growth factor 164; vascular endothelial growth factor 165b; vascular endothelial growth factor 182; vascular endothelial growth factor 182 isoform; vascular endothelial growth factor 188; vascular endothelial growth factor 188 isoform; vascular endothelial growth factor 189; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular endothelial growth factor Aa; Vascular endothelial growth factor A-A; vascular endothelial growth factor isoform 165; vascular permeability factor; Vasculotropin; VEGF; VEGF1; VEGF164; VEGF182; VEGF188; vegfa; VEGF-A; VEGFA165b; vegfaa; VEGF-A-A; VEGFMGC70609; VPF; VPF ant; wu:fj82c06
更多信息或购买 :
公司信息
赛默飞世尔